Details

Health Canada implementation of International Council for Harmonisation Q12 Technical and regulatory considerations for pharmaceutical product lifecycle management and Q14 Analytical procedure development: Notice - Canada.ca

Metadata and links for an archived snapshot.

Source
Health Canada
Date
Apr 11, 2026 · edition #6
Timestamp
2026-04-11T15:08:35.461Z
Language
en
ID
371698
Status
200
Type
text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots

Archived page preview